Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Expanded national database collection and data coverage in the FINDbase worldwide database for clinically relevant genomic variation allele frequencies.

Viennas E, Komianou A, Mizzi C, Stojiljkovic M, Mitropoulou C, Muilu J, Vihinen M, Grypioti P, Papadaki S, Pavlidis C, Zukic B, Katsila T, van der Spek PJ, Pavlovic S, Tzimas G, Patrinos GP.

Nucleic Acids Res. 2017 Jan 4;45(D1):D846-D853. doi: 10.1093/nar/gkw949. Epub 2016 Oct 18.

2.

SIN1, a critical component of the mTOR-Rictor complex, is overexpressed and associated with AKT activation in medullary and aggressive papillary thyroid carcinomas.

Moraitis D, Karanikou M, Liakou C, Dimas K, Tzimas G, Tseleni-Balafouta S, Patsouris E, Rassidakis GZ, Kouvaraki MA.

Surgery. 2014 Dec;156(6):1542-8; discussion 1548-9. doi: 10.1016/j.surg.2014.08.095. Epub 2014 Nov 11.

PMID:
25456951
3.

Exploiting expert systems in cardiology: a comparative study.

Economou GP, Sourla E, Stamatopoulou KM, Syrimpeis V, Sioutas S, Tsakalidis A, Tzimas G.

Adv Exp Med Biol. 2015;820:79-89. doi: 10.1007/978-3-319-09012-2_6.

PMID:
25417018
4.

Introducing dAUTObase: a first step towards the global scale geoepidemiology of autoimmune syndromes and diseases.

Gkantouna VA, Kambouris ME, Viennas ES, Ioannou ZM, Paraskevas M, Lagoumintzis G, Zagoriti Z, Patrinos GP, Tzimas GE, Poulas K.

Bioinformatics. 2015 Feb 15;31(4):581-6. doi: 10.1093/bioinformatics/btu690. Epub 2014 Oct 20.

PMID:
25332376
5.

DruGeVar: an online resource triangulating drugs with genes and genomic biomarkers for clinical pharmacogenomics.

Dalabira E, Viennas E, Daki E, Komianou A, Bartsakoulia M, Poulas K, Katsila T, Tzimas G, Patrinos GP.

Public Health Genomics. 2014;17(5-6):265-71. doi: 10.1159/000365895. Epub 2014 Sep 9.

PMID:
25228099
6.

Developments in FINDbase worldwide database for clinically relevant genomic variation allele frequencies.

Papadopoulos P, Viennas E, Gkantouna V, Pavlidis C, Bartsakoulia M, Ioannou ZM, Ratbi I, Sefiani A, Tsaknakis J, Poulas K, Tzimas G, Patrinos GP.

Nucleic Acids Res. 2014 Jan;42(Database issue):D1020-6. doi: 10.1093/nar/gkt1125. Epub 2013 Nov 14.

7.

Magnitude of change in alpha-fetoprotein in response to transarterial chemoembolization predicts survival in patients undergoing liver transplantation for hepatocellular carcinoma.

Bhat M, Hassanain M, Simoneau E, Tzimas GN, Chaudhury P, Deschenes M, Valenti D, Ghali P, Wong P, Cabrera T, Barkun J, Tchervenkov JI, Metrakos P.

Curr Oncol. 2013 Oct;20(5):265-72. doi: 10.3747/co.20.1270.

8.

Updates of the HbVar database of human hemoglobin variants and thalassemia mutations.

Giardine B, Borg J, Viennas E, Pavlidis C, Moradkhani K, Joly P, Bartsakoulia M, Riemer C, Miller W, Tzimas G, Wajcman H, Hardison RC, Patrinos GP.

Nucleic Acids Res. 2014 Jan;42(Database issue):D1063-9. doi: 10.1093/nar/gkt911. Epub 2013 Oct 16.

9.

Microattribution and nanopublication as means to incentivize the placement of human genome variation data into the public domain.

Patrinos GP, Cooper DN, van Mulligen E, Gkantouna V, Tzimas G, Tatum Z, Schultes E, Roos M, Mons B.

Hum Mutat. 2012 Nov;33(11):1503-12. doi: 10.1002/humu.22144. Epub 2012 Jul 23.

PMID:
22736453
10.

Population-ethnic group specific genome variation allele frequency data: a querying and visualization journey.

Viennas E, Gkantouna V, Ioannou M, Georgitsi M, Rigou M, Poulas K, Patrinos GP, Tzimas G.

Genomics. 2012 Aug;100(2):93-101. doi: 10.1016/j.ygeno.2012.05.009. Epub 2012 May 30.

11.

Institutional Profile: Golden Helix Institute of Biomedical Research: interdisciplinary research and educational activities in pharmacogenomics and personalized medicine.

Mitropoulos K, Innocenti F, van Schaik RH, Lezhava A, Tzimas G, Kollia P, Macek M Jr, Fortina P, Patrinos GP.

Pharmacogenomics. 2012 Mar;13(4):387-92. doi: 10.2217/pgs.12.7.

12.

Population-specific documentation of pharmacogenomic markers and their allelic frequencies in FINDbase.

Georgitsi M, Viennas E, Gkantouna V, Christodoulopoulou E, Zagoriti Z, Tafrali C, Ntellos F, Giannakopoulou O, Boulakou A, Vlahopoulou P, Kyriacou E, Tsaknakis J, Tsakalidis A, Poulas K, Tzimas G, Patrinos GP.

Pharmacogenomics. 2011 Jan;12(1):49-58. doi: 10.2217/pgs.10.169.

PMID:
21174622
13.

FINDbase: a worldwide database for genetic variation allele frequencies updated.

Georgitsi M, Viennas E, Antoniou DI, Gkantouna V, van Baal S, Petricoin EF 3rd, Poulas K, Tzimas G, Patrinos GP.

Nucleic Acids Res. 2011 Jan;39(Database issue):D926-32. doi: 10.1093/nar/gkq1236. Epub 2010 Nov 27.

14.

Intestinal neurofibromatosis and small-bowel adenocarcinoma: a single case study.

Stratopoulos C, Papakonstantinou A, Anagnostopoulos G, Terzis I, Tzimas G, Gourgiotis S, Vamvouka C, Hadjiyannakis E.

Eur J Cancer Care (Engl). 2009 Sep;18(5):466-9. doi: 10.1111/j.1365-2354.2007.00888.x.

PMID:
19473375
15.

Proteomics analysis of liver pathological calcification suggests a role for the IQ motif containing GTPase activating protein 1 in myofibroblast function.

Kalantari F, Auguste P, Ziafazeli T, Tzimas G, Malmström L, Bioulac-Sage P, Boismenu D, Vali H, Chevet E.

Proteomics Clin Appl. 2009 Mar;3(3):307-21. doi: 10.1002/prca.200780133.

PMID:
26238749
16.

The MAP kinase phosphatase-1 MKP-1/DUSP1 is a regulator of human liver response to transplantation.

Boutros T, Nantel A, Emadali A, Tzimas G, Conzen S, Chevet E, Metrakos PP.

Am J Transplant. 2008 Dec;8(12):2558-68. doi: 10.1111/j.1600-6143.2008.02420.x.

17.

Liver transplantation for metastases from a bile duct carcinoid.

Tzimas GN, Vali K, Deschênes M, Marcus VA, Barkun JS, Tchervenkov JI, Metrakos PP.

HPB (Oxford). 2006;8(1):67-8. doi: 10.1080/13651820600573170.

18.

Cellular and molecular mechanisms of abnormal calcification following ischemia-reperfusion injury in human liver transplantation.

Kalantari F, Miao D, Emadali A, Tzimas GN, Goltzman D, Vali H, Chevet E, Auguste P.

Mod Pathol. 2007 Mar;20(3):357-66.

19.

Preoperative alpha-fetoprotein slope is predictive of hepatocellular carcinoma recurrence after liver transplantation.

Han K, Tzimas GN, Barkun JS, Metrakos P, Tchervenkov JL, Hilzenrat N, Wong P, Deschênes M.

Can J Gastroenterol. 2007 Jan;21(1):39-45.

20.

Novel two-step resection for lesions between the middle hepatic vein and vena cava which allows the middle hepatic vein to be preserved.

Horton PJ, Chaudhury PK, Znajda TL, Martinie JB, Rochon C, Tzimas GN, Metrakos P.

J Gastrointest Surg. 2006 Jan;10(1):69-76.

PMID:
16368493
21.

Abnormal expression and processing of the proprotein convertases PC1 and PC2 in human colorectal liver metastases.

Tzimas GN, Chevet E, Jenna S, Nguyên DT, Khatib AM, Marcus V, Zhang Y, Chrétien M, Seidah N, Metrakos P.

BMC Cancer. 2005 Nov 17;5:149.

22.

Distinct endoplasmic reticulum stress responses are triggered during human liver transplantation.

Emadali A, Nguyên DT, Rochon C, Tzimas GN, Metrakos PP, Chevet E.

J Pathol. 2005 Sep;207(1):111-8.

PMID:
15912576
23.

Regulation of membrane trafficking by a novel Cdc42-related protein in Caenorhabditis elegans epithelial cells.

Jenna S, Caruso ME, Emadali A, Nguyên DT, Dominguez M, Li S, Roy R, Reboul J, Vidal M, Tzimas GN, Bossé R, Chevet E.

Mol Biol Cell. 2005 Apr;16(4):1629-39. Epub 2005 Jan 19.

24.

Correlation of cell necrosis and tissue calcification with ischemia/reperfusion injury after liver transplantation.

Tzimas GN, Afshar M, Emadali A, Chevet E, Vali H, Metrakos PP.

Transplant Proc. 2004 Jul-Aug;36(6):1766-8.

PMID:
15350473
25.

Leukoreduction and acute rejection in liver transplantation: an interim analysis.

Tzimas GN, Deschenes M, Barkun JS, Wong P, Tchervenkov JI, Hayati H, Alpert E, Metrakos P.

Transplant Proc. 2004 Jul-Aug;36(6):1760-2.

PMID:
15350471
26.
27.

Graft calcifications and dysfunction following liver transplantation.

Tzimas GN, Afshar M, Chevet E, Emadali A, Vali H, Metrakos PP.

BMC Surg. 2004 Sep 3;4:9.

28.

Positron emission tomography and colorectal carcinoma: an update.

Tzimas GN, Koumanis DJ, Meterissian S.

J Am Coll Surg. 2004 Apr;198(4):645-52. Review. No abstract available.

PMID:
15051018
29.

Do biliary endoprostheses decrease biliary complications after liver transplantation?

Barkun JS, Tzimas GN, Cantarovich M, Metrakos PP, Deschênes M, Alpert E, Paraskevas S, Tchervenkov JI.

Transplant Proc. 2003 Nov;35(7):2435-7.

PMID:
14611980
30.

Ureteral implantation technique and urologic complications in adult kidney transplantion.

Tzimas GN, Hayati H, Tchervenkov JI, Metrakos PP.

Transplant Proc. 2003 Nov;35(7):2420-2.

PMID:
14611976
31.

Early onset, nefazodone-induced fulminant hepatic failure.

Tzimas GN, Dion B, Deschênes M.

Am J Gastroenterol. 2003 Jul;98(7):1663-4. No abstract available.

PMID:
12873607
32.

Efficacy of mycophenolate mofetil combined with very low-dose cyclosporine microemulsion in long-term liver-transplant patients with renal dysfunction.

Cantarovich M, Tzimas GN, Barkun J, Deschênes M, Alpert E, Tchervenkov J.

Transplantation. 2003 Jul 15;76(1):98-102.

PMID:
12865793
33.

Distribution of endogenous retinoids, retinoid binding proteins (RBP, CRABPI) and nuclear retinoid X receptor beta (RXRbeta) in the porcine embryo.

Schweigert FJ, Siegling C, Tzimas G, Seeger J, Nau H.

Reprod Nutr Dev. 2002 Jul-Aug;42(4):285-94.

PMID:
12510870
34.

Aberrant right hepatic artery: a mockery.

Tzimas GN, Barkun JS, Metrakos P, Tchervenkov JI.

Liver Transpl. 2002 Apr;8(4):411. No abstract available.

35.

Vitamin A teratogenicity and risk assessment in the macaque retinoid model.

Tzimas G, Nau H.

Reprod Toxicol. 2001 Jul-Aug;15(4):445-7. No abstract available.

PMID:
11515502
36.

The role of metabolism and toxicokinetics in retinoid teratogenesis.

Tzimas G, Nau H.

Curr Pharm Des. 2001 Jun;7(9):803-31. Review.

PMID:
11375780
37.

Serum vitamin A is elevated in idiopathic intracranial hypertension.

Sass JO, Arnhold T, Tzimas G, Jacobson DM.

Neurology. 2000 Jun 13;54(11):2192-3. No abstract available.

PMID:
10851402
38.

Paronychia with pyogenic granuloma in a child treated with indinavir: the retinoid-mediated side effect theory revisited.

Sass JO, Jakob-Sölder B, Heitger A, Tzimas G, Sarcletti M.

Dermatology. 2000;200(1):40-2.

PMID:
10681612
39.

Human uterine leiomyomata express higher levels of peroxisome proliferator-activated receptor gamma, retinoid X receptor alpha, and all-trans retinoic acid than myometrium.

Tsibris JC, Porter KB, Jazayeri A, Tzimas G, Nau H, Huang H, Kuparadze K, Porter GW, O'Brien WF, Spellacy WN.

Cancer Res. 1999 Nov 15;59(22):5737-44.

40.

Retinoid teratogenicity in the macaque: verification of dosing regimen.

Hendrickx AG, Tzimas G, Korte R, Hummler H.

J Med Primatol. 1998 Dec;27(6):310-8.

PMID:
10203012
42.

9,13-Dicis-retinoic acid as an isomerization product of 9-cis-retinoic acid.

Sass JO, Tzimas G, Nau H.

Drug Metab Dispos. 1997 Dec;25(12):1447-8. No abstract available.

45.

Proliferating cell nuclear antigen and heat shock protein 70 immunolocalization in invasive ductal breast cancer not otherwise specified.

Lazaris ACh, Chatzigianni EB, Panoussopoulos D, Tzimas GN, Davaris PS, Golematis BCh.

Breast Cancer Res Treat. 1997 Mar;43(1):43-51.

PMID:
9065598
46.
47.
48.

Identification of 14-hydroxy-4,14-retro-retinol as an in vivo metabolite of vitamin A.

Tzimas G, Collins MD, Nau H.

Biochim Biophys Acta. 1996 May 31;1301(1-2):1-6.

PMID:
8652644
49.

Supplemental Content

Loading ...
Support Center